2seventy bio, Inc.
TSVT · NASDAQ
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 683.9% | -78.4% | 50.9% | – |
| Gross Profit | $0 | -$0 | $0 | $0 |
| % Margin | 77.5% | -202.2% | 57.4% | 85% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -3.6% | -732.7% | -87% | -208.3% |
| Net Income | $0 | -$0 | -$0 | $0 |
| % Margin | 2.1% | -667.1% | -73.4% | 277.5% |
| EPS Diluted | 0.009 | -0.37 | -0.19 | 0.45 |
| % Growth | 102.5% | -94.7% | -142.2% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | $0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |